Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Cefepime"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 3733
Tytuł:
Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter ephesus study.
Autorzy:
Sipahi OR; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, Izmir, Turkey.; Department of Infectious Diseases, Bahrain Oncology Center, King Hamad University Hospital, Muharraq, Bahrain.
Akyol D; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, Izmir, Turkey. .; Infectious Diseases Clinic, Kagizman State Hospital, Kagizman, Kars, Turkey. .
Ormen B; Infectious Diseases and Clinical Microbiology Clinic, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey.
Cicek-Senturk G; Infectious Diseases and Clinical Microbiology Clinic, SB Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.
Mermer S; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, Izmir, Turkey.; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ekonomi University, Izmir, Turkey.
Onal U; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, Izmir, Turkey.; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Uludag University, Bursa, Turkey.
Amer F; Zagazig University, Zagazig, Egypt.
Saed MA; Zagazig University, Zagazig, Egypt.
Ozdemir K; Department of Infectious Diseases and Clinical Microbiology, Pamukkale University, Denizli, Turkey.
Tukenmez-Tigen E; Department of Infectious Diseases and Clinical Microbiology, Marmara University, Istanbul, Turkey.
Oztoprak N; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Uludag University, Bursa, Turkey.; Infectious Diseases and Clinical Microbiology Clinic, Antalya Education and Research Hospital, Antalya, Turkey.
Altin U; Infectious Diseases and Clinical Microbiology Clinic, Bozyaka Training and Research Hospital, Izmir, Turkey.
Kurtaran B; Department of Infectious Diseases and Clinical Microbiology, Cukurova University, Adana, Turkey.
Popescu CP; Dr Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania.
Sakci M; Medical Student, Faculty of Medicine, Ege University, Izmir, Turkey.
Suntur BM; Infectious Diseases and Clinical Microbiology Clinic, Adana Numune Training and Research Hospital, Adana, Turkey.
Gautam V; Post-Graduate Institute of Medical Education & Research, Chandigarh, India.
Sharma M; Department of Microbiology, All India Institute of Medical Sciences (AIIMS), Bilaspur, Himachal Pradesh, India.
Kaya S; Infectious Diseases and Clinical Microbiology Clinic, Gazi Yasargil Education and Research Hospital, Diyarbakir, Turkey.
Akcil EF; Department of Anaesthesiology and Reanimation, Istanbul University, Istanbul, Turkey.
Kaya S; Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, Karadeniz Technical University, Trabzon, Turkey.
Turunc T; Department of Infectious Diseases and Clinical Microbiology, Baskent University, Adana, Turkey.
Ergen P; Department of Infectious Diseases and Clinical Microbiology, Istanbul Medeniyet University, Goztepe Educational and Research Hospital, Istanbul, Turkey.
Kandemir O; Department of Infectious Diseases and Clinical Microbiology, Mersin University School of Medicine, Mersin, Turkey.
Cesur S; Infectious Diseases and Clinical Microbiology Clinic, Ankara Training Hospital, Ankara, Turkey.
Bardak-Ozcem S; Department of Infectious Diseases and Clinical Microbiology, Dr. Burhan Nalbantoğlu State Hospital, Nicosia, Northern Cyprus.
Ozgiray E; Department of Neurosurgery, Faculty of Medicine, Ege University, Izmir, Turkey.
Yurtseven T; Department of Neurosurgery, Faculty of Medicine, Ege University, Izmir, Turkey.
Erdem HA; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, Izmir, Turkey.
Sipahi H; Bornova Public Health Center, Izmir, Turkey.
Arda B; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, Izmir, Turkey.
Pullukcu H; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, Izmir, Turkey.
Tasbakan M; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, Izmir, Turkey.
Yamazhan T; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, Izmir, Turkey.
Aydemir S; Department of Clinical Microbiology, Faculty of Medicine, Ege University, Izmir, Turkey.
Ulusoy S; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, Izmir, Turkey.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2023 Sep 28; Vol. 23 (1), pp. 639. Date of Electronic Publication: 2023 Sep 28.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Vancomycin*/therapeutic use
Meningitis*/drug therapy
Humans ; Meropenem/therapeutic use ; Cefepime/therapeutic use ; Ceftazidime/therapeutic use ; Retrospective Studies ; Anti-Bacterial Agents/therapeutic use ; Bacteria ; Staphylococcus ; Delivery of Health Care ; Ampicillin
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A case of meningitis caused by Ralstonia insidiosa, a rare opportunistic pathogen.
Autorzy:
Liao L; Department of Clinical Pharmacy, The First People's Hospital of Neijiang, 641000, Neijiang, China.
Lin D; Department of Clinical Pharmacy, The First People's Hospital of Neijiang, 641000, Neijiang, China.
Liu Z; Department of Clinical Pharmacy, The First People's Hospital of Neijiang, 641000, Neijiang, China.
Gao Y; Department of Clinical Pharmacy, The First People's Hospital of Neijiang, 641000, Neijiang, China.
Hu K; Department of Clinical Pharmacy, The First People's Hospital of Neijiang, 641000, Neijiang, China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2023 Aug 22; Vol. 23 (1), pp. 548. Date of Electronic Publication: 2023 Aug 22.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Levofloxacin*
Meningitis*
Humans ; Cefepime ; Ralstonia ; Anti-Bacterial Agents/therapeutic use
SCR Organism:
Ralstonia insidiosa
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cefepime versus carbapenems for treatment of AmpC beta-lactamase-producing Enterobacterales bloodstream infections.
Autorzy:
Herrmann, Julia (AUTHOR)
Burgener-Gasser, Anne-Valérie (AUTHOR)
Goldenberger, Daniel (AUTHOR)
Roth, Jan (AUTHOR)
Weisser, Maja (AUTHOR)
Tamma, Pranita D. (AUTHOR)
Tschudin-Sutter, Sarah (AUTHOR)
Pokaż więcej
Źródło:
European Journal of Clinical Microbiology & Infectious Diseases. Feb2024, Vol. 43 Issue 2, p213-221. 9p.
Czasopismo naukowe
Szczegóły
Tytuł:
Efficacy, safety, and tolerability of antimicrobial agents for complicated intra-abdominal infection: a systematic review and network meta-analysis.
Autorzy:
Kong W; Department of Pharmacy, Zi Gong First People's Hospital, Zi Gong, China.
Deng T; Department of Pharmacy, Women and Children's Hospital of Chongqing Medical University, Chongqing, China.
Li S; Department of Pharmacy, Zi Gong First People's Hospital, Zi Gong, China.
Shu Y; Department of Pharmacy, Zi Gong First People's Hospital, Zi Gong, China.
Wu Y; Department of Pharmacy, Women and Children's Hospital of Chongqing Medical University, Chongqing, China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2023 Apr 21; Vol. 23 (1), pp. 256. Date of Electronic Publication: 2023 Apr 21.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Intraabdominal Infections*/drug therapy
Intraabdominal Infections*/microbiology
Anti-Infective Agents*/adverse effects
Adult ; Humans ; Metronidazole/adverse effects ; Meropenem/therapeutic use ; Network Meta-Analysis ; Tigecycline/therapeutic use ; Cefepime/therapeutic use ; Anti-Bacterial Agents/adverse effects ; Tazobactam/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A case-control study of Clostridioides difficile symptomatic infections in a pediatric cancer hospital.
Autorzy:
Silva AMPSD; Instituto de Oncologia Pediátrica, São Paulo, SP, Brazil.
Barbosa LC; Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Marques LMA; Hospital Alemão Oswaldo Cruz, São Paulo, SP, Brazil.
Carreira LY; Instituto de Oncologia Pediátrica, São Paulo, SP, Brazil.
Fonseca FMCD; Instituto de Oncologia Pediátrica, São Paulo, SP, Brazil.
Lima APC; Instituto Adolfo Lutz, São Paulo, SP, Brazil.
Sodré JJM; Instituto de Oncologia Pediátrica, São Paulo, SP, Brazil.
Pignati LT; Universidade de São Paulo, São Paulo, SP, Brazil.
Araújo OR; Instituto de Oncologia Pediátrica, São Paulo, SP, Brazil.
Silva DCBD; Instituto de Oncologia Pediátrica, São Paulo, SP, Brazil.
Carlesse FAMC; Instituto de Oncologia Pediátrica, São Paulo, SP, Brazil.
Pokaż więcej
Źródło:
Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo [Rev Paul Pediatr] 2023 Mar 13; Vol. 41, pp. e2022117. Date of Electronic Publication: 2023 Mar 13 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Clostridioides difficile*
Cross Infection*/epidemiology
Cross Infection*/chemically induced
Cross Infection*/drug therapy
Clostridium Infections*/epidemiology
Clostridium Infections*/chemically induced
Clostridium Infections*/drug therapy
Neoplasms*/complications
Humans ; Child ; Case-Control Studies ; Retrospective Studies ; Vancomycin ; Cefepime/therapeutic use ; Meropenem ; Busulfan/therapeutic use ; Melphalan/therapeutic use ; Asparaginase/therapeutic use ; Cancer Care Facilities ; Carboplatin/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Molecular Dynamic Analysis of Carbapenem-Resistant Klebsiella pneumonia 's Porin Proteins with Beta Lactam Antibiotics and Zinc Oxide Nanoparticles.
Autorzy:
Elsayim R; Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Aloufi AS; Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
Modafer Y; Department of Biology, College of Science, Jazan University, Jazan 45142, Saudi Arabia.
Eltayb WA; Biotechnology Department, Faculty of Science and Technology, Shendi University, Shendi 11111, Nher Anile, Sudan.
Alameen AA; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Abdurahim SA; Department of Microbiology, College of Medicine, Al-Rayan Colleges, AL Madinah Al Monawara 41411, Saudi Arabia.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Mar 09; Vol. 28 (6). Date of Electronic Publication: 2023 Mar 09.
Typ publikacji:
Journal Article
MeSH Terms:
Zinc Oxide*/chemistry
Nanoparticles*/chemistry
Pneumonia*
Metal Nanoparticles*/chemistry
Humans ; Carbapenems/pharmacology ; Meropenem/pharmacology ; Klebsiella/metabolism ; Cefepime ; Porins/metabolism ; Molecular Dynamics Simulation ; Ligands ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/chemistry ; Imipenem/pharmacology ; Monobactams ; Microbial Sensitivity Tests ; Klebsiella pneumoniae/metabolism ; Spectroscopy, Fourier Transform Infrared
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates.
Autorzy:
Vanstokstraeten, R. (AUTHOR)
Piérard, D. (AUTHOR)
Crombé, F. (AUTHOR)
De Geyter, D. (AUTHOR)
Wybo, I. (AUTHOR)
Muyldermans, A. (AUTHOR)
Seyler, L. (AUTHOR)
Caljon, B. (AUTHOR)
Janssen, T. (AUTHOR)
Demuyser, T. (AUTHOR)
Pokaż więcej
Źródło:
Scientific Reports. 1/9/2023, Vol. 12 Issue 1, p1-7. 7p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
First report of qnr and blaVIM-4-like producing clinical Alcaligenes faecalis isolated in Türkiye.
Autorzy:
AKYILDIZ, Esma
SARIYER, Ayşegül SARAL
KÖSE, Tuba
ARSLAN, Mikail
BERİŞ, Fatih Şaban
DÜZGÜN, Azer ÖZAD
Pokaż więcej
Alternatywny tytuł:
Türkiye'den izole edilen qnr ve blaVIM-4-like üreten klinik Alcaligenes faecalis’in ilk raporu.
Źródło:
Gümüshane Üniversitesi Fen Bilimleri Enstitüsü Dergisi. 2023, Vol. 13 Issue 1, p57-65. 9p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[Fatal Outcome of Agranulocytosis after Re-Exposure to Metamizole and Cefepime-Induced Encephalopathy].
Autorzy:
Skaistys A; 1 Universitäre Altersmedizin FELIX PLATTER, Basel.
Rätz Bravo AE; 1 Universitäre Altersmedizin FELIX PLATTER, Basel.
Leuppi-Taegtmeyer A; 3 Klinische Pharmakologie & Toxikologie, Universitätsspital Basel.
Zysset Y; 1 Universitäre Altersmedizin FELIX PLATTER, Basel.
Pokaż więcej
Transliterated Title:
Agranulozytose nach Metamizol-Reexposition und Cefepim-induzierte Enzephalopathie mit fatalem Ausgang.
Źródło:
Praxis [Praxis (Bern 1994)] 2019 Aug; Vol. 108 (10), pp. 693-697.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Agranulocytosis*/chemically induced
Anti-Bacterial Agents*/adverse effects
Anti-Inflammatory Agents, Non-Steroidal*/adverse effects
Cefepime*/adverse effects
Dipyrone*/adverse effects
Aged, 80 and over ; Brain Diseases ; Fatal Outcome ; Female ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Carbapenem-resistant Pseudomonas aeruginosa: an assessment of frequency of isolation from ICU versus non-ICU, phenotypic and genotypic profiles in a multinational population of hospitalized patients.
Autorzy:
Gill CM; Center for Anti-Infective Research & Development Hartford Hospital, 80 Seymour Street, Hartford, CT, 06102, USA.
Nicolau DP; Center for Anti-Infective Research & Development Hartford Hospital, 80 Seymour Street, Hartford, CT, 06102, USA. .; Division of Infectious Diseases, Hartford Hospital, Hartford, CT, USA. .
Pokaż więcej
Corporate Authors:
ERACE-PA Global Study Group
Źródło:
Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2022 Nov 30; Vol. 11 (1), pp. 146. Date of Electronic Publication: 2022 Nov 30.
Typ publikacji:
Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Pseudomonas aeruginosa*/genetics
Ceftazidime*/pharmacology
Cefepime ; Phenotype ; Tazobactam ; Carbapenems/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sensitive and selective bioscreening of the most commonly used coronavirus disease drug, Favipiravir, and its co‐administered therapeutic, Meropenem, in human plasma.
Autorzy:
Abdelfatah, Rehab M. (AUTHOR)
Abdelaleem, Eglal A. (AUTHOR)
Abdelmomen, Esraa H. (AUTHOR)
Abdelmoety, Refaat H. (AUTHOR)
Emam, Aml A. (AUTHOR)
Pokaż więcej
Źródło:
Journal of Separation Science. Oct2022, Vol. 45 Issue 20, p3800-3810. 11p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Design of an Experimental Study for the Simultaneous Determination of Cefepime, Piperacillin and Tazobactam Using Micellar Organic Solvent-Free HPLC.
Autorzy:
Hafez, Hani M. (AUTHOR)
El Deeb, Sami (AUTHOR)
Naji, Esraa Abd Alkareem (AUTHOR)
Aziz, Zahraa Ali (AUTHOR)
Mahmood, Amaal Sajid (AUTHOR)
Khalil, Nooralhuda Ibrahim (AUTHOR)
Ibrahim, Adel Ehab (AUTHOR)
Pokaż więcej
Źródło:
Separations (2297-8739). Aug2022, Vol. 9 Issue 8, p215-215. 13p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 3733

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies